rs185464679
Variant summary
Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBP6BS1
The NM_001378452.1(ITPR1):c.2107G>A(p.Asp703Asn) variant causes a missense change. The variant allele was found at a frequency of 0.000036 in 1,610,944 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. D703D) has been classified as Likely benign.
Frequency
Consequence
NM_001378452.1 missense
Scores
Clinical Significance
Conservation
Publications
- aniridia-cerebellar ataxia-intellectual disability syndromeInheritance: AD, AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, G2P, Genomics England PanelApp, PanelApp Australia, Labcorp Genetics (formerly Invitae), Orphanet, ClinGen
- spinocerebellar ataxia type 29Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), G2P, ClinGen, Orphanet
- spinocerebellar ataxia type 15/16Inheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -9 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| ITPR1 | NM_001378452.1 | c.2107G>A | p.Asp703Asn | missense_variant | Exon 20 of 62 | ENST00000649015.2 | NP_001365381.1 | |
| ITPR1 | NM_001168272.2 | c.2062G>A | p.Asp688Asn | missense_variant | Exon 19 of 61 | NP_001161744.1 | ||
| ITPR1 | NM_001099952.4 | c.2107G>A | p.Asp703Asn | missense_variant | Exon 20 of 59 | NP_001093422.2 | ||
| ITPR1 | NM_002222.7 | c.2062G>A | p.Asp688Asn | missense_variant | Exon 19 of 58 | NP_002213.5 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| ITPR1 | ENST00000649015.2 | c.2107G>A | p.Asp703Asn | missense_variant | Exon 20 of 62 | NM_001378452.1 | ENSP00000497605.1 | |||
| ITPR1 | ENST00000354582.12 | c.2107G>A | p.Asp703Asn | missense_variant | Exon 20 of 62 | 5 | ENSP00000346595.8 | |||
| ITPR1 | ENST00000648266.1 | c.2107G>A | p.Asp703Asn | missense_variant | Exon 20 of 62 | ENSP00000498014.1 | ||||
| ITPR1 | ENST00000650294.1 | c.2062G>A | p.Asp688Asn | missense_variant | Exon 19 of 61 | ENSP00000498056.1 | ||||
| ITPR1 | ENST00000443694.5 | c.2062G>A | p.Asp688Asn | missense_variant | Exon 19 of 61 | 1 | ENSP00000401671.2 | |||
| ITPR1 | ENST00000648309.1 | c.2062G>A | p.Asp688Asn | missense_variant | Exon 17 of 59 | ENSP00000497026.1 | ||||
| ITPR1 | ENST00000357086.10 | c.2107G>A | p.Asp703Asn | missense_variant | Exon 20 of 59 | 1 | ENSP00000349597.4 | |||
| ITPR1 | ENST00000456211.8 | c.2062G>A | p.Asp688Asn | missense_variant | Exon 19 of 58 | 1 | ENSP00000397885.2 | |||
| ITPR1 | ENST00000648038.1 | c.-57G>A | upstream_gene_variant | ENSP00000497872.1 |
Frequencies
GnomAD3 genomes AF: 0.0000526 AC: 8AN: 152190Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000820 AC: 20AN: 243822 AF XY: 0.0000530 show subpopulations
GnomAD4 exome AF: 0.0000343 AC: 50AN: 1458636Hom.: 0 Cov.: 32 AF XY: 0.0000234 AC XY: 17AN XY: 725236 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000525 AC: 8AN: 152308Hom.: 0 Cov.: 32 AF XY: 0.0000537 AC XY: 4AN XY: 74486 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not provided Uncertain:1Benign:2
- -
In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge -
- -
Inborn genetic diseases Uncertain:1
The c.2062G>A (p.D688N) alteration is located in exon 19 (coding exon 17) of the ITPR1 gene. This alteration results from a G to A substitution at nucleotide position 2062, causing the aspartic acid (D) at amino acid position 688 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at